Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:52:01 UTC |
---|
HMDB ID | HMDB0015565 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Etoricoxib |
---|
Description | Etoricoxib, also known as L791456 or MK-663, belongs to the class of organic compounds known as bipyridines and oligopyridines. These are organic compounds containing two pyridine rings linked to each other. Etoricoxib is a drug which is used for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. In humans, etoricoxib is involved in the etoricoxib action pathway. Etoricoxib is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a small amount of articles have been published on Etoricoxib. |
---|
Structure | CC1=NC=C(C=C1)C1=C(C=C(Cl)C=N1)C1=CC=C(C=C1)S(C)(=O)=O InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3 |
---|
Synonyms | Value | Source |
---|
5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine | ChEBI | 5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl | ChEBI | 5-Chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine | ChEBI | Etoricoxibum | ChEBI | L791456 | ChEBI | 5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulphonyl)phenyl)pyridine | Generator | 5-Chloro-3-(4-methanesulphonyl-phenyl)-6'-methyl-[2,3']bipyridinyl | Generator | 5-Chloro-6'-methyl-3-(p-(methylsulphonyl)phenyl)-2,3'-bipyridine | Generator | MK-663 | HMDB | Arcoxia | HMDB |
|
---|
Chemical Formula | C18H15ClN2O2S |
---|
Average Molecular Weight | 358.842 |
---|
Monoisotopic Molecular Weight | 358.054276131 |
---|
IUPAC Name | 5-chloro-3-(4-methanesulfonylphenyl)-2-(6-methylpyridin-3-yl)pyridine |
---|
Traditional Name | etoricoxib |
---|
CAS Registry Number | 202409-33-4 |
---|
SMILES | CC1=NC=C(C=C1)C1=C(C=C(Cl)C=N1)C1=CC=C(C=C1)S(C)(=O)=O |
---|
InChI Identifier | InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3 |
---|
InChI Key | MNJVRJDLRVPLFE-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as bipyridines and oligopyridines. These are organic compounds containing two pyridine rings linked to each other. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Pyridines and derivatives |
---|
Sub Class | Bipyridines and oligopyridines |
---|
Direct Parent | Bipyridines and oligopyridines |
---|
Alternative Parents | |
---|
Substituents | - Bipyridine
- 3-phenylpyridine
- Benzenesulfonyl group
- Methylpyridine
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Sulfone
- Sulfonyl
- Heteroaromatic compound
- Azacycle
- Hydrocarbon derivative
- Organosulfur compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Organic oxide
- Organopnictogen compound
- Organic nitrogen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0033 g/L | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Etoricoxib GC-MS (Non-derivatized) - 70eV, Positive | splash10-00c3-1195000000-a6512b3342a7ab34b539 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Etoricoxib GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Etoricoxib GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etoricoxib 10V, Positive-QTOF | splash10-0a4i-0009000000-f7a7b2b391bf2c553bee | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etoricoxib 20V, Positive-QTOF | splash10-0a4i-0019000000-ee3806388a3685ebb2ea | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etoricoxib 40V, Positive-QTOF | splash10-014l-1093000000-f6befa9e036305228b8a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etoricoxib 10V, Negative-QTOF | splash10-0a4i-0009000000-50b1220eaafc5cd21ae9 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etoricoxib 20V, Negative-QTOF | splash10-0a4i-0019000000-7f9d7c868b2e84a344d8 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etoricoxib 40V, Negative-QTOF | splash10-004i-7193000000-02c1e0800c4c34dc4627 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etoricoxib 10V, Positive-QTOF | splash10-0a4i-0009000000-fa58affcccc87c3233cb | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etoricoxib 20V, Positive-QTOF | splash10-0a4i-0009000000-dcccff10c50c0a3a450b | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etoricoxib 40V, Positive-QTOF | splash10-00pr-1092000000-eccb7f42163f67d408a9 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etoricoxib 10V, Negative-QTOF | splash10-0a4i-0009000000-6292d183612a368493ec | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etoricoxib 20V, Negative-QTOF | splash10-053r-9005000000-b2f21f92017e3512dfc2 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etoricoxib 40V, Negative-QTOF | splash10-0059-9030000000-9d3d76f515503b2f8eba | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|